{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:28:57Z","timestamp":1747171737441,"version":"3.40.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.transci.2019.06.030","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T11:32:49Z","timestamp":1562671969000},"page":"525-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inpatient management strategies in a severe case of heparin-induced thrombocytopenia"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7789-7184","authenticated-orcid":false,"given":"Aaron D.","family":"Shmookler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Arays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2019.06.030_bib0005","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.transci.2019.06.030_bib0010","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/trf.14316","article-title":"How do I \u2026 manage the platelet transfusion-refractory patient?","volume":"57","author":"Juskewitch","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.06.030_bib0015","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/S2352-3026(18)30046-2","article-title":"Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study","volume":"5","author":"Dhakal","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.transci.2019.06.030_bib0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2019.06.030_bib0025","first-page":"29","article-title":"Plasmapheresis in the management of heparin-induced thrombocytopenia","volume":"36","author":"Robinson","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2019.06.030_bib0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jca.20289","article-title":"Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literature","volume":"26","author":"Jaben","year":"2011","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2019.06.030_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.transci.2013.01.007","article-title":"Refractory heparin induced thrombocytopenia with thrombosis (HITT) treated with therapeutic plasma exchange and rituximab as adjuvant therapy","volume":"49","author":"Schell","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2019.06.030_bib0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2014-07-590844","article-title":"Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities","volume":"125","author":"Warkentin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.06.030_bib0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1373\/jalm.2017.023929","article-title":"Effects of plasma exchange and heparin concentration on the serotonin release assay in heparin-induced thrombocytopenia","volume":"2","author":"Tillman","year":"2017","journal-title":"J Appl Lab Med AACC Publ"},{"key":"10.1016\/j.transci.2019.06.030_bib0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jca.21671","article-title":"Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: a challenging case and a survey of the field","volume":"34","author":"Cho","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2019.06.030_bib0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.transci.2018.06.007","article-title":"Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia","volume":"57","author":"Park","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"May (5)","key":"10.1016\/j.transci.2019.06.030_bib0060","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/jth.14411","article-title":"High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome","volume":"17","author":"Mohanty","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2019.06.030_bib0065","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/trf.15105","article-title":"Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia","volume":"59","author":"Irani","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.06.030_bib0070","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2019.06.030_bib0075","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/trf.14289","article-title":"Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti\u2010blood group A and B antibodies and individual susceptibility","volume":"57","author":"Mielke","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2019.06.030_bib0080","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.chest.2017.03.050","article-title":"IVIg for treatment of severe refractory heparin-induced thrombocytopenia","volume":"152","author":"Padmanabhan","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.transci.2019.06.030_bib0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.thromres.2017.03.010","article-title":"Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL \u00ae HIT-Ab (PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia","volume":"153","author":"Warkentin","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2019.06.030_bib0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jca.2920100410","article-title":"Immunologic rebound","volume":"10","author":"Dau","year":"1995","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2019.06.030_bib0095","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2014-09-599498","article-title":"Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study","volume":"125","author":"Kang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.06.030_bib0100","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.jacc.2017.09.1099","article-title":"Use of fondaparinux off-label or approved anticoagulants for management of heparin-induced thrombocytopenia","volume":"70","author":"Schindewolf","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transci.2019.06.030_bib0105","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.transci.2019.06.030_bib0110","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood-2017-04-778993","article-title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","volume":"130","author":"Warkentin","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2019.06.030_bib0115","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","author":"Cuker","year":"2018","journal-title":"Blood Adv"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219301375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219301375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T16:10:05Z","timestamp":1567527005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050219301375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1473050219301375"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.06.030","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inpatient management strategies in a severe case of heparin-induced thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}